Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Honliv Healthcare Management Group Co Ltd ( (HK:9906) ) is now available.
Honliv Healthcare Management Group has received formal resumption guidance from the Hong Kong Stock Exchange after trading in its shares was suspended following delayed 2025 audited results and the resignation of its auditor. The exchange’s directives reflect heightened regulatory scrutiny of the company’s governance, financial reporting and internal controls, with potential implications for investor confidence and the company’s standing in the market.
Under the resumption guidance, Honliv must commission an independent forensic investigation into a disputed loan and related fund transfers, assess their impact on its operations and finances, and disclose findings along with remedial actions. The company is also required to overhaul and independently review its internal controls, clear all outstanding financial results, prove ongoing compliance with listing requirements and Rule 13.24, and resolve these issues before an 18‑month deadline to avoid potential delisting.
More about Honliv Healthcare Management Group Co Ltd
Honliv Healthcare Management Group Company Limited is a healthcare services provider operating through a group structure, with its shares listed on the Hong Kong Stock Exchange. The group focuses on hospital operations and related medical services, and is subject to Hong Kong’s Listing Rules and securities regulatory framework.
Average Trading Volume: 2,000
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$936M
See more data about 9906 stock on TipRanks’ Stock Analysis page.